What is the recommended management for bloating?

Treatment for Bloating

Start with dietary modifications supervised by a gastroenterology dietitian, specifically a low-FODMAP diet trial for 2 weeks, while simultaneously ruling out carbohydrate enzyme deficiencies through dietary restriction before considering breath testing. 1

Initial Diagnostic Approach

Before initiating treatment, use Rome IV criteria to diagnose primary abdominal bloating and distention, ensuring the patient does not meet criteria for IBS, functional constipation, functional diarrhea, or functional dyspepsia. 1

Key clinical distinctions to identify:

• Whether constipation is present (requires different treatment pathway)
• Presence of alarm features (weight loss >10%, GI bleeding, vomiting, family history of IBD)
• Timing of symptoms (meal-related vs. constant)
• Associated symptoms (nausea, vomiting, pain severity)

Rule out organic causes first:

• Celiac disease via serologic testing (confirm with small bowel biopsy if positive) 1
• Carbohydrate intolerances (lactose, fructose, sucrose) through 2-week dietary restriction trial 1
• Small intestinal bacterial overgrowth (SIBO) only in at-risk patients using breath testing or small bowel aspiration 1

Avoid unnecessary testing: Do not order abdominal imaging, upper endoscopy, or gastric emptying studies unless alarm features, recent symptom worsening, or abnormal physical examination findings are present. 1

Treatment Algorithm

First-Line: Dietary Interventions

Low-FODMAP diet is the primary dietary intervention, requiring supervision by a gastroenterology dietitian. 1 This addresses fermentable oligosaccharides, disaccharides, monosaccharides, and polyols that cause osmotic effects and gas production in patients with visceral hypersensitivity.

Common food intolerances to address:

• Fructose intolerance (present in 60% of DGBI patients)
• Lactose intolerance (51% prevalence)
• Artificial sweeteners (sugar alcohols, sorbitol)

Second-Line: Pharmacological Treatments

If constipation is present, treat it first as this often resolves bloating. 1

Medications proven superior to placebo for bloating in IBS-C include:

• Linaclotide 290 µg daily (most efficacious, NNT=7, ranked highest in network meta-analysis) 2
• Lubiprostone 8 µg twice daily
• Tenapanor 50 mg twice daily
• Plecanatide

Central neuromodulators for visceral hypersensitivity: 1

• Tricyclic antidepressants (amitriptyline) - activate noradrenergic and serotonergic pathways
• Serotonin-norepinephrine reuptake inhibitors (duloxetine, venlafaxine)
• Pregabalin

These work by reducing visceral hypersensitivity, raising sensation thresholds, and improving psychological comorbidities. They are particularly effective when distention occurs during or after meals.

Critical caveat: Probiotics should NOT be used to treat abdominal bloating and distention - they may cause brain fogginess, bloating, and lactic acidosis. 1

Third-Line: Behavioral and Biofeedback Therapies

Brain-gut behavioral therapies (can be combined with pharmacotherapy): 1

• Cognitive behavioral therapy
• Gut-directed hypnotherapy
• Diaphragmatic breathing (particularly for abdominophrenic dyssynergia)

Biofeedback therapy is specifically indicated when: 1

• Pelvic floor disorder is identified through anorectal physiology testing
• Bloating is associated with constipation or difficult evacuation
• Response rate: 54% achieve 50% reduction in bloating scores

This uses operant-conditioning techniques to correct dyssynergic defecation and abnormal viscerosomatic reflexes.

Special Consideration: Abdominophrenic Dyssynergia (APD)

For patients with paradoxical diaphragmatic contraction and abdominal wall relaxation causing visible distention:

• Diaphragmatic breathing exercises 1
• Central neuromodulators (work by reducing the bloating sensation that triggers the abnormal reflex) 1

This is most effective when distention occurs during or immediately after meals, less effective for constant bloating.

Common Pitfalls to Avoid

1. Do not routinely order gastric emptying studies unless nausea and vomiting are prominent features 1
2. Do not use probiotics - insufficient evidence and potential adverse effects 1
3. Do not skip dietary assessment - food intolerances are the most economical diagnosis via 2-week restriction trial 1
4. Do not treat SIBO empirically - antibiotics (including rifaximin) are not FDA-approved for this indication and require careful patient selection 1

Treatment Sequencing

For bloating with constipation: Treat constipation first with secretagogues (linaclotide preferred) → add central neuromodulators if inadequate response → consider biofeedback if pelvic floor disorder identified

For bloating without constipation: Low-FODMAP diet trial → central neuromodulators for visceral hypersensitivity → brain-gut behavioral therapies → biofeedback if APD suspected

For refractory cases: Combine central neuromodulators with brain-gut behavioral therapies, as they work synergistically and safely together 1